600mg Ibuprofeno Tiocolchicosido USP Tablets
50 INR/Box
Product Details:
X
600mg Ibuprofeno Tiocolchicosido USP Tablets Price And Quantity
- 50 INR/Box
- 5000 Box
600mg Ibuprofeno Tiocolchicosido USP Tablets Trade Information
- Cash Advance (CA)
- Days
- Western Europe Central America Asia Australia South America Middle East Eastern Europe North America Africa
Product Description
600mg Ibuprofeno Tiocolchicosido USP Tablets are a combination of two active ingredients, ibuprofen and tiocolchicoside. These tablets are used for various functions, including reducing inflammation and pain, relaxing muscles, and improving mobility. The tablets are formulated in a convenient tablet form, making it easy for users to take them with warm water. These tablets are suitable for all ages and can be stored in a dry and cool place.
FAQs of 600mg Ibuprofeno Tiocolchicosido USP Tablets:
Q: What are the active ingredients in these tablets?
A: The active ingredients in these tablets are ibuprofen and tiocolchicoside.Q: What are the functions of these tablets?
A: These tablets are used for various functions, including reducing inflammation and pain, relaxing muscles, and improving mobility.Q: How should I take these tablets?
A: These tablets should be taken with warm water according to the dosage guidelines.Q: Are these tablets suitable for all ages?
A: Yes, these tablets are suitable for all ages.Q: How should I store these tablets?
A: These tablets should be stored in a dry and cool place.Enter Buying Requirement Details
Other Products in 'Pharmaceutical Injection' category
BRIX BIOPHARMA PVT LTD
GST : 27AAICB7477P1ZR
GST : 27AAICB7477P1ZR
Contact Details
- B No. 907, 9th Floor, Sunshine Tower, Senapati Bapat Marg, Dadar West, Mumbai - 400013, Maharashtra, India
- Phone :08045800361
- Mr Raj Jain (Export Manager)
- Mobile :08045800361
-
Send Inquiry
Send Inquiry
BRIX BIOPHARMA PVT LTD
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
